Japan Drug Approvals | 日本の医薬品承認 | ニュース | 日本のニュース速報 | 健康管理 | 2024 | iPharmaCenter
Dupixent approved for chronic spontaneous urticaria Japan became the first country to approve Dupixent for chronic spontaneous urticaria...
Japan Drug Approvals | 日本の医薬品承認 | ニュース | 日本のニュース速報 | 健康管理 | 2024 | iPharmaCenter
Japan Drug Approvals | 2023 | MHLW | PMDA | iPharmaCenter
Levima received orphan designation from MHLW |Japan drug approvals | Japan Healthcare System
Lynparza was approved for three more indications in Japan
Merck’s Keytruda received one more indication and dosage form approval in Japan
Gilead announced the positive Phase 3 trial of remdesivir in COVID-19 patients
Astellas received approval for Xtandi in Japan for prostate cancer
AstraZeneca's Lokelma approved in Japan